Tiotropium/Salmeterol Inhalation Powder in COPD

Summary

The primary objectives of this study are to assess bronchodilator efficacy as determined by forced expiratory volume in one second (FEV1), the effect on dyspnoea as determined by the Baseline Dyspnoea Index (BDI)/Transition Dyspnoea Index (TDI), the effect on health status as determined by the St George Respiratory Questionnaire (SGRQ) and the effect on chronic obstructive pulmonary disease (COPD) exacerbations

Timeline

Start

2008-04-15

Primary completion

2008-11-21

Completion

2008-11-21

Drugs

Indications